Sunshine Biopharma, Inc. (SBFM)
0.243
+0.01
(+2.84%)
USD |
NASDAQ |
Oct 14, 16:00
0.2292
-0.01
(-5.68%)
After-Hours: 20:00
Sunshine Biopharma Gross Profit Margin (Quarterly) : 25.35% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.35% |
| March 31, 2026 | 26.01% |
| December 31, 2025 | 34.16% |
| September 30, 2025 | 31.62% |
| June 30, 2025 | 35.60% |
| March 31, 2025 | 29.95% |
| December 31, 2024 | 31.55% |
| September 30, 2024 | 33.21% |
| June 30, 2024 | 24.78% |
| March 31, 2024 | 30.66% |
| December 31, 2023 | 32.89% |
| September 30, 2023 | 32.78% |
| June 30, 2023 | 34.49% |
| March 31, 2023 | 36.64% |
| December 31, 2022 | 37.36% |
| September 30, 2022 | 49.85% |
| June 30, 2022 | 48.77% |
| Date | Value |
|---|---|
| March 31, 2022 | 48.69% |
| December 31, 2021 | 24.21% |
| September 30, 2021 | 54.96% |
| June 30, 2021 | 58.98% |
| March 31, 2021 | 45.89% |
| December 31, 2020 | 50.00% |
| September 30, 2020 | 42.44% |
| June 30, 2020 | 43.05% |
| March 31, 2020 | 33.33% |
| December 31, 2019 | 27.36% |
| September 30, 2019 | -19.18% |
| June 30, 2019 | -60.00% |
| March 31, 2019 | -8.20K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 72.82% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.91% |
| Return on Assets | -18.80% |
| Return on Invested Capital | -23.15% |
| Profit Margin (Quarterly) | -16.88% |
| Operating Margin (Quarterly) | -17.41% |
| Return on Net Operating Assets | -27.73% |